Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1792625Generated: November 4, 2026

6-Bromo-4-[4-(2-methylsulfonylphenoxy)-piperidin-1-yl] quinoline → 4-[4-(2-methylsulfonylphenoxy)piperidin-1-yl]-6-(3-trifluoromethyl-1-trityl-1H-pyrazol-4-yl) quinoline

https://huagongshe.com/reaction/1792625

Reaction equation

Participants

RoleNameHCIDCharge
Reactant6-Bromo-4-[4-(2-methylsulfonylphenoxy)-piperidin-1-yl] quinolineHCID 22031271—
Reactant[3-(Trifluoromethyl)-1-trityl-1H-pyrazol-4-YL]boronic acidHCID 22032227—
Product4-[4-(2-methylsulfonylphenoxy)piperidin-1-yl]-6-(3-trifluoromethyl-1-trityl-1H-pyrazol-4-yl) quinolineHCID 6881537194.2%

Reaction Steps

80 mg 6-bromo-4-[4-(2-methylsulfonylphenoxy)-piperidin-1-yl] quinoline (compound in Production Example 222) and 95 mg 3-trifluoromethyl-1-trityl-1H-4-pyrazolylboronic acid (compound in Production Example 31) were reacted in the same manner as in Example 9, to give 124 mg 4-[4-(2-methylsulfonylphenoxy)piperidin-1-yl]-6-(3-trifluoromethyl-1-trityl-1H-pyrazol-4-yl) quinoline. This product was reacted in the same manner as in Example 67, to give 70 mg of the title compound as colorless crystals.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07074801B1
Source datasetuspto-grants-2006_07
ORD IDord-ae4eadedae4b473b8faa9d7438f2e2d0
Source noteuspto-grants-2006_07